Sunk, Ilse-Gerlinde
Amoyo-Minar, Love
Niederreiter, Birgit
Soleiman, Afschin
Kainberger, Franz
Smolen, Josef S.
Aletaha, Daniel
Bobacz, Klaus
Article History
Received: 17 February 2022
Accepted: 7 September 2022
First Online: 29 September 2022
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the ethics committee of the Medical University of Vienna (No.: 409/2005).
: Not applicable.
: Dr. Smolen received grants to his institution from Abbvie, AstraZeneca, Janssen, Lilly, Merck Sharpe & Dohme, Pfizer, and Roche and provided expert advice for, or had symposia speaking engagements with, AbbVie, Amgen, AstraZeneca, Astro, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Gilead, ILTOO Pharma, Janssen, Lilly, Merck Sharp & Dohme, Novartis-Sandoz, Pfizer, Roche, Samsung, Sanofi, and UCB.Dr. Aletaha reports grants from Abbvie, Amgen, Novartis, Roche, SoBi, Sanofi, personal fees from Abbvie, Amgen, Lilly, Merck, Novartis, Pfizer, Roche, Sandoz, outside the submitted work.